AWARE INC /MA/

AWARE INC /MA/ Q3 FY2011 earnings

AWRE

Quarter ended Sep 2011.

← Q2 FY2011Q4 FY2011 →
Revenue
$4.9M
Gross margin
84.2%
Operating margin
25.9%
Net income
$1.3M

Summary

The company's fiscal 2011 third quarter, ended September 30, 2011, produced a decisive swing in profitability. Revenue was $6.42 million, up 4.4% from $6.15 million in the prior-year quarter. Operating income reached $1.27 million, compared with an operating loss of $0.05 million a year earlier. The operating margin was 19.8%, up from -0.8%. Net income was $1.28 million, and diluted EPS was $0.06 against $0.00 in the prior-year quarter.

The nine-month picture looks similar. Revenue for the nine months ended September 30, 2011 was $18.69 million, up 11.7% from $16.74 million in the first nine months of 2010. Operating income was $1.56 million versus an operating loss of $0.54 million, and the year-to-date operating margin improved to 8.4% from -3.2%. Net income was $1.61 million, with diluted EPS of $0.08 compared with $0.00 a year earlier.

Mix changed sharply. Product sales slipped 2%, from $5.0 million to $4.9 million, and fell from 82% to 76% of total revenue. Test and diagnostic hardware revenue dropped $0.8 million because customers delayed purchases until an upgraded hardware line with a new DSL chipset is ready. Test software revenue fell $0.5 million on long sales cycles for LDP software. Biometrics software revenue rose $1.2 million on several larger license transactions. Services revenue climbed 99%, from $0.5 million to $1.0 million, and went from 8% to 15% of revenue on biometrics engineering work. Royalties declined 14%, from $0.6 million to $0.5 million, and still depend heavily on Ikanos and Lantiq.

Costs fell faster than revenue in several lines. Cost of product sales dropped 37%, from $1.2 million to $0.8 million, lifting product gross margins to 84% from 75%. Research and development expense fell 12%, from $2.1 million to $1.8 million, partly because $208,000 more engineering cost was classified into cost of services. General and administrative expense fell 34%, from $1.7 million to $1.1 million, on lower director and officer compensation and lower legal fees. Selling and marketing expense held at $1.0 million. Cost of services rose 101%, from $206,000 to $414,000, and services gross margins eased to 57.4% from 57.7% as work shifted toward larger, slightly less profitable projects.

Cash and the balance sheet remain the strongest part of the story. Operating cash flow was $3.10 million in the quarter versus -$0.05 million a year earlier, and $4.95 million for the nine months versus -$0.21 million. Capital expenditures were $34,000 in the quarter, flat with the prior-year quarter, and $122,000 for the nine months, up 20.8% from $101,000. Cash and cash equivalents were $45.5 million at September 30, 2011, up $5.6 million from December 31, 2010. Deferred revenue, current portion only, was $1.23 million. The company repurchased 250,000 shares in July 2011 for $735,000.

The filing gives no specific guidance for the next quarter or the full fiscal year. Management instead lists uncertainties. It says it cannot predict whether services revenue or royalties will trend upward or downward, and it questions whether licensees can hold chipset market share and pricing. The patent management line recorded no patent related services revenue in the three and nine month periods, and the board is still reviewing options that include a spin-off, a sale or a licensing deal. Taxes are not a near-term cash issue, since a full valuation allowance still covers the company's deferred tax assets and management expects to offset net income with existing carryforwards.

Forecast

Management guidance

No forward guidance in this quarter's filings.

Reported figures

GAAP, from SEC filings
MetricQ3 FY2011Q2 FY2011QoQQ3 FY2010YoY
Revenue$4.9M$4.0M+22.6%——
Gross profit$4.1M$2.9M+41.8%——
Gross margin84.2%72.8%+11.4 pp——
Research & development$1.8M$1.8M+1.2%——
Sales & marketing$1.0M$1.1M-1.4%——
General & administrative$1.1M$1.8M-39.5%——
Total operating expenses$5.2M$6.2M-16.9%——
Operating income (loss)$1.3M-$283.0K+549.5%——
Operating margin25.9%-7.1%+33.0 pp——
Net income (loss)$1.3M-$267.0K+580.9%——
Net margin26.2%-6.7%+32.9 pp——
Diluted EPS$0.06-$0.01+$0.07——

Risks

HIGHConcentration Risk

Royalty revenue currently comes predominantly from DSL chipset sales by Ikanos Communications and Lantiq Deutschland, and royalties decreased in the third quarter and year to date. The company remains uncertain whether these licensees can maintain their market shares and chipset prices in the face of intense competition.

MEDIUMProduct Transition

Customers are delaying test and diagnostic hardware purchases until the company completes upgrading its hardware product line with a new DSL chipset, which contributed to lower product sales in the third quarter.

MEDIUMSales Cycle

Lower sales of LDP software were driven by long sales cycles to potential service provider customers, contributing to a decrease in test and diagnostic software revenue in the third quarter.

MEDIUMRevenue Concentration

Biometrics software revenue increased in the third quarter primarily due to several larger-sized license transactions, making quarterly results dependent on a small number of deals.

MEDIUMStrategic Transaction

The board is reviewing strategic options for the patent management operations, including a potential spin-off, sale, or licensing of patents, with no assurance as to timing, structure, or completion.

MEDIUMRevenue Predictability

Services revenue increased due to biometrics engineering services, but management is unable to predict whether services revenue will trend upward or downward in future periods.

MEDIUMManagement Transition

General and administrative expense decreased partly due to lower compensation, but was partially offset by severance expenses incurred upon the resignation of the former President and CEO in April 2011.

Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q3 FY2011 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Nov 5, 2026.